Mandy Budwal-Jagait

Mandy Budwal-Jagait is a GCP inspector with the MHRA and joined the Agency in April 2014. Mandy conducts a variety of GCP inspections in commercial and non-commercial organisations, including Phase I units registered under the MHRA Phase I Accreditation Scheme.

Prior to joining the Agency, Mandy has held Clinical Research and Quality Assurance roles in the Pharmaceutical Industry. She holds a MSc in Toxicology and BSc (Hons) in Medical Biochemistry.

Sponsor Oversight- Part 2

Posted by: Mandy Budwal-Jagait, Posted on: 25 September 2018 - Categories: Compliance matters, Good clinical practice

Part two of this post provides two case studies from inspections where critical and major findings have been identified in regards to Organisation’s Oversight of Clinical Trials of IMP.

Sponsor Oversight- Part 1

Posted by: Mandy Budwal-Jagait, Posted on: 26 July 2018 - Categories: Compliance matters, Good clinical practice

The first of two posts focusing on sponsor oversight and how to improve compliance in this area.

GCP Symposium 2018

Posted by: Mandy Budwal-Jagait, Posted on: 31 May 2018 - Categories: Compliance matters, Events and symposia, Good clinical practice

Find out how to register for the 2018 GCP Symposium.

MHRA GCP Symposium 2016

Posted by: Mandy Budwal-Jagait, Posted on: 18 October 2016 - Categories: Compliance matters, Events and symposia, Good clinical practice

The annual GCP Symposium was held by the MHRA on 20 September 2016 in Birmingham and was repeated on the 21 September 2016.